Related Experiment Video
Updated: May 29, 2026
10:17
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Biventricular pacing: current trends and future strategies.
1Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02459, USA. jsingh@partners.org
European Heart Journal
|September 29, 2011
Summary
Biventricular pacing, or cardiac resynchronization therapy (CRT), is now used for less symptomatic heart failure (HF) patients. CRT improves quality of life and reduces hospitalizations, though some patients remain unresponsive.
Area of Science:
- Cardiology
- Medical Technology
Background:
- Biventricular pacing, or cardiac resynchronization therapy (CRT), is increasingly used for heart failure (HF) patients.
- Its application is expanding to include less symptomatic individuals earlier in their disease progression.
Purpose of the Study:
- To review the current state of biventricular pacing for heart failure.
- To explore strategies for improving patient response to CRT.
- To outline future directions for optimizing CRT benefits.
Main Methods:
- This is a review article.
- It synthesizes current literature on biventricular pacing and cardiac resynchronization therapy.
Main Results:
- Biventricular pacing favorably impacts cardiac remodeling and ejection fraction in HF patients.
- This leads to improved quality of life, functional capacity, and reduced HF hospitalizations and mortality.
- A significant subset of patients do not respond to current CRT strategies.
Conclusions:
- CRT has demonstrated significant clinical benefits in heart failure management.
- Further research is needed to enhance patient response rates and optimize therapeutic outcomes.
- Future trends aim to maximize the potential of this pacing modality.
More Related Videos
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.